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OBJECTIVES The purpose of this study was to evaluate the prognostic importance of ischemic episodes
detected by ST-segment monitoring with continuous 12-lead electrocardiography (ECG) in
a nonselected coronary care unit (CCU) population with chest pain and ECG nondiagnostic
of acute myocardial infarction (AMI).
BACKGROUND Patients with chest pain and ECG nondiagnostic of AMI constitute a heterogeneous group
concerning both diagnosis and prognosis. Continuous 12-lead ECG is a rather new method
not thoroughly studied in this population.
METHODS The ST-segment monitoring with continuous 12-lead ECG was performed for 12 h in 630
consecutive patients admitted to CCU due to chest pain and a nondiagnostic ECG, i.e., no
ST-segment elevations. An ST-episode was defined as a transient ST-segment depression or
elevation of at least 0.10 mV. The median follow-up time was six months.
RESULTS A total of 176 ST-episodes occurred in 100 (15.9%) patients. The median duration and
maximal ST-segment deviation in patients with ST-episodes were 80 min and 0.20 mV,
respectively. Presence of ST-episodes predicted worse outcome concerning cardiac death and
cardiac death or myocardial infarction (MI) (log-rank p , 0.001). At 30 day follow-up
procedure, 10% versus 1.5% died from cardiac causes or had an MI in the group with and
without ST-episodes, respectively. In a multivariate analysis, only troponin T $0.10 mg/l and
the presence of ST-episodes came out as independent predictors of cardiac death or MI.
CONCLUSIONS Continuous 12-lead ECG monitoring provides prognostic information on-line and consid-
erably improves early risk stratification in patients with ECG nondiagnostic of AMI and
symptoms suggestive of acute coronary syndrome. (J Am Coll Cardiol 1999;34:1413–9) ©
1999 by the American College of Cardiology
Patients with chest pain suggestive of acute coronary syn-
drome and electrocardiogram (ECG) nondiagnostic of
acute myocardial infarction (AMI) constitute a heteroge-
neous group concerning both diagnosis and future risk of
cardiac events (1,2). Early risk stratification is essential for
further treatment and management and is usually based on
clinical characteristics, 12-lead ECG and biochemical
markers (3).
In patients with unstable coronary artery disease
(UCAD), i.e., unstable angina and non–Q-wave myocardial
infarction (MI), presence of ischemic episodes during ST-
segment recording with the Holter technique has in several
studies been related to worse outcome (4–13). However, the
Holter-technique has been limited to 2 to 3 leads and is an
off line method, which means that the results have not been
provided until several hours or days after the ischemic
episodes. This has probably caused the limited use of Holter
monitoring in clinical practice.
Recently, new technologies have been introduced, pro-
viding on line ST-segment monitoring with continuous
12-lead ECG or vectorcardiography (VCG) (14,15).
Whereas several studies have presented results with VCG
(16,17), very limited data are available concerning continu-
ous 12-lead ECG in the population with UCAD (18,19).
The aims of this prospective study were to evaluate, in a
nonselected coronary care unit (CCU) population admitted
because of chest pain and with ECG nondiagnostic of AMI,
the prognostic importance of ischemic episodes detected by
ST-segment monitoring with continuous 12-lead ECG and
compare it with well known prognostic factors such as
clinical variables, ECG on admission and biochemical
markers.
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METHODS
Patient selection. In the FAST study (Fast Assessment of
Thoracic pain), patients admitted to the CCU in one
university hospital were eligible for participation between
March 1997 and February 1998. The inclusion criterion was
a history of chest pain or other symptoms suggestive of an
acute coronary syndrome. Exclusion criteria were pre-
hospital thrombolysis, presence of ST-segment elevation
($0.20 mV in V1-V4, $0.10 mV in other leads) on
admission ECG, ECG not interpretable for ischemia (left
bundle branch block [LBBB], pacemaker treatment, atrio-
ventricular block or ventricular rhythm) or previous inclu-
sion in this study. After a run in period of two months,
consecutive patients were included.
Of the 1,194 eligible patients, 131 were excluded due to
prehospital thrombolysis or ST-segment elevation on ad-
mission ECG, 170 because of previous enrollment in the
study and 90 because of an ECG not interpretable for
ischemia. Another 173 patients were excluded because of
less than 9 h of monitoring, due to technical reasons or a
need for fast turnover of CCU beds. Thus, 630 patients with
at least 9 h of ST-segment monitoring during the first 12 h
from admission were included in this analysis.
All clinical data were prospectively collected and entered
into the local database of the National Registry for Cardiac
Intensive Care. The treatment of individual patients was left
to the discretion of the individual physician. Because this
was an observational study and all investigations were done
according to the local clinical routines, including the col-
lection of clinical data in the local database of the National
Registry for Cardiac Intensive Care, informed consent was
considered unnecessary according to the local ethics com-
mittee who approved the study. However, all patients
received written information and could refuse participation
in this study and entering of any data in the database.
ECG on admission. A 12-lead ECG was obtained from
the continuous 12-lead ECG system on admission to CCU
and was interpreted centrally and without knowledge of the
outcome. The ST-segment depression was defined as a
depression of the ST-segment of $0.05 mV below the
isoelectric line in any lead. T-wave inversion was defined as
a negative or isoelectric T-wave in leads V2–V6, I and II, in
aVL if R . 0.5 mV and in aVF if R . Q and R . S.
Laboratory analysis. Blood samples for immediate analy-
ses of creatine-kinase isoenzyme (CK-MB) (mass) and
Troponin T at the central laboratory were obtained on
admission, after 6 and 12 h, and, if needed, at later time
points. Creatine-kinase isoenzyme MB (mass) was analyzed
by the IMx method (Abbot Laboratories, Abbot Park,
Illinois) with a decision limit for myocardial damage of
6 mg/l and for AMI of 10 mg/l. Troponin T was determined
by the Enzymun-Test system (Boehringer-Mannheim,
Mannheim, Germany) with a decision limit for myocardial
damage of 0.10 mg/l.
ST-segment monitoring. The ST-segment monitoring
was started with the admission ECG as the first acquired
ECG and then performed for 12 h, using a continuous
ST-segment monitoring software package, ST-Guard (GE
Marquette Medical Systems, Milwaukee, Wisconsin). This
software calculates each min from the last 10 s of monitor-
ing median QRS-T complexes for each of the 12 leads.
From these QRS-T complexes an ST-trend for each lead is
constructed, stored and displayed online. The online ST-
trends were displayed during the stay in the CCU and,
hence, were known to the emergency physician.
Central analysis of ST-monitoring. The ST-trends were
stored on floppy disks and later analyzed centrally by a
well-trained physician (TJ) without knowledge of clinical
outcome. Artifacts were removed before analysis. The ST-
segment changes due to changes in body position were
defined as sudden ST-segment changes with simultaneous
changes of QRS- and T-wave amplitudes.
If the first acquired ECG had no signs of ischemia, this
was chosen as the reference ECG. Otherwise, an ECG as
close as possible to normal, at a time point as soon as
possible after admission, was chosen. An ST-episode was
defined as a transient ST-segment depression or elevation in
any lead of at least 0.1 mV compared with the reference
ECG, lasting for at least 1 min. Hence, patients with
persistent ST-segment depressions were not classified as
having ST-episodes. Episodes had to be separated by at
least 1 min to be regarded as two separate episodes. In order
to reduce the effect of heart rate, ST-segment changes were
measured at J-point 1 (1/16 3 R-R interval), correspond-
ing to J-point 1 60 ms at a heart rate of 62.5 beats per
minute. The time from start of monitoring to start of the
first ST-episode, the number of ST-episodes, the total
duration of ST-episodes and the maximal degree of ST-
depression or elevation compared with the reference ECG
during an episode were recorded. The recurrence of chest
pain was not monitored.
Follow-up. The median follow up time was six months
(range 1 to 13 months). The end points were cardiac death
and cardiac death or MI at 30 days and at the end of
follow-up. All in hospital events were registered in the local
database of the National Registry for Cardiac Intensive
Care. Only new MIs occurring more than 24 h after
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CCU 5 coronary care unit
CK-MB 5 creatine kinase isoenzyme
ECG 5 electrocardiography
LBBB 5 left bundle branch block
MI 5 myocardial infarction
UCAD 5 unstable coronary artery disease
VCG 5 vectorcardiography
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admission were considered as new events. Out of hospital
information about death and cause of death was obtained
from the National Registry on Mortality. Information on
MI was obtained from the hospital diagnosis registry and
patients’ records. This information will contain the com-
plete information on all admissions to the only hospital
providing hospital care for acute diseases for the present
patient population. For the diagnosis of acute MI, as well at
the index as at recurrent events, one of the following should
be fulfilled:
1) pathologic Q waves (duration .0.03 s and amplitude
$25% of R) developing in at least two leads,
2) symptoms suggestive of acute MI or nondiagnostic ECG
changes and typical elevated levels of biochemical mark-
ers with CK-MB (mass) $10 mg/l,
3) symptoms suggestive of AMI and ST-segment elevation
or LBBB and further diagnostics not possible, or
4) signs of AMI at autopsy.
Statistical analysis. All data analysis was performed using
the Statistical Package for Social Sciences (SPSS 8.0.0)
software (SPSS Inc., Chicago, Illinois). Differences in
proportions were judged by chi-square analysis using Yates’
correction and by Fisher exact test as appropriate. A
significant difference was considered to exist with p , 0.05.
The cumulative survival curves were constructed using the
Kaplan-Meier method. The end points were cardiac death
alone and cardiac death or MI. Statistical assessment was
performed using the log-rank test with p , 0.05 considered
as significant. To identify predictors of the double end
point— cardiac death or MI—the univariate Cox regres-
sion analyses were used after all variables had been
checked for proportional hazards. The following dichot-
omized variables were introduced in the analyses: pres-
ence or not of age $70, male gender, diabetes mellitus,
hypertension, current smoking, history of previous MI,
previous revascularization, peak-value of troponin T
$0.10 mg/l, peak-value of CK-MB (mass) $6 mg/l, ST-
segment depression $0.05 mV on admission ECG, ST-
segment depression $0.10 mV on admission ECG, isolated
T-wave inversion on admission ECG and ST-episodes
during monitoring. The results were expressed as relative
risk with a 95% confidence interval together with the p value
from the log-rank test. All variables with a p , 0.05 were
then tested in a multivariate Cox regression analysis using
forward stepwise selection. Variables were entered if p ,
0.05 and removed if p , 0.10.
RESULTS
General findings. The clinical characteristics and findings
in the ECG on admission of the 630 patients are shown in
Table 1. During the first 24 h from admission, 163 patients
(26%) were classified as having an acute MI, 192 (30%) had
unstable angina or angina, whereas 64 (10%) were consid-
ered to have other cardiac causes to their symptoms and 211
(33%) had noncardiac or unknown causes. Creatine-kinase
isoenzyme MB (mass) $6 mg/l was present in at least one
sample in 216 (34%) patients, whereas 193 (31%) had at
least one sample of Troponin T $0.10 mg/l. During the
follow-up period there were 32 (5.1%) deaths, of which 24
(3.8%) were cardiac deaths. Forty-four (7.0%) had an MI.
ST-segment monitoring. A total of 176 ischemic episodes
occurred in 100 (15.9%) patients during ST-segment mon-
itoring. Of these, 87 patients had only episodes of ST-
segment depression, 5 patients had only episodes of ST-
segment elevation and 8 patients had both depressions and
elevations of the ST-segment. More than one episode was
present in 36 patients. The episodes were located in the
anterior or anterolateral leads in 62 (62%), inferior or
inferolateral leads in nine (9%) and in both anterior and
inferior leads in 29 (29%). The median duration of ischemia
in patients with episodes was 80 min (25th to 75th percen-
tile: 30 to 167), whereas the median value of the maximal
ST-segment deviation of each patient was 0.20 mV (25th to
75th percentile: 0.15–0.29 mV). Sixty-one (61%) of the
patients with ST-episodes had their first episodes at start of
monitoring, whereas, of the remaining 39, 36 patients
(92%), had their first episodes during the first 6 h from
admission.
The number of patients with ST-episodes in relation to
admission ECG and diagnosis are shown in Tables 2 and 3,
respectively. There was a significantly higher proportion of
patients with ST-episodes in the group with ST-segment
depressions $0.10 mV and the group with AMI on
admission compared with the other groups (p , 0.001).
Predictors of outcome. In the univariate analysis (Table
4), the only clinical variables significantly predicting cardiac
death or MI were age $70 years, diabetes mellitus and
previous MI. Both Troponin T $0.10 mg/l and CK-MB
Table 1. Clinical Characteristics of the Study Population
(n 5 630)
Baseline Variables n %
Age, mean (SD) (yr) 67 (13)
Male 375 59.5
Diabetes mellitus 112 17.8
Hypertension 247 39.2
Current smoker 107 17.0
Previous myocardial infarction 195 31.0
Previous revascularisation 103 16.3
Previous congestive heart failure 126 20.0
Time from onset of chest pain to admission
Median (25th–75th percentile) (h)
4.9 (2.3–10.2)
ECG on admission
Normal ECG 206 32.7
ST-depression $0.05 mV ,0.10 mV 127 20.2
ST-depression $0.10 mV 123 19.5
Isolated T-wave inversions 51 8.1
Other pathologic ECG 123 19.5
n 5 number of patients; % 5 percentage of the study population.
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(mass) $6 mg/l predicted worse outcome with a respective
6.9-fold and 5.9-fold increased risk of subsequent cardiac
death or MI compared with those without this finding.
Whereas ST-segment depression on admission ECG was a
significant predictor, isolated T-wave inversions was not.
For the end points of cardiac death alone and cardiac
death or MI, the presence of ST-episodes predicted a worse
outcome (Fig. 1, log-rank p , 0.001). All patients were
followed for 30 days. During this period there were 10
(10%) and 8 (1.5%) patients who died from cardiac causes or
who had an MI in the group with and without ST-episodes,
respectively. During the entire follow-up period, there were
24 (24%) versus 24 (4.5%) cardiac deaths or MIs.
In the multivariate analysis, including all characteristics
showed to be significant predictors in the univariate analysis
(Table 4), only Troponin T $0.10 mg/l (p , 0.001) and
presence of ST-episodes (p 5 0.004) were independent
predictors of cardiac death or MI. Presence of ST-episodes
was a better predictor of worse outcome than ST-segment
depression $0.10 mV on admission-ECG. For patients
with and without ST-segment depression $0.10 mV on
admission, the occurrence of ST-episodes at monitoring
added significantly to prognostic information (Fig. 2).
DISCUSSION
Background. Patients admitted to CCU due to chest pain
or other symptoms suggestive of an acute coronary syn-
drome and ECG nondiagnostic of AMI encompass a
heterogeneous group that varies widely as well regarding
diagnosis as future risk for cardiac events (20). There are
several potential benefits with early risk stratification in this
group. Patients identified as having a high risk of subse-
quent event might need a more intense pharmacologic
treatment and should be considered for earlier interventions
than patients with a low risk, in whom a more conservative
approach might be appropriate. Considerable economic
gains may be achieved by early identification of patients who
are at sufficiently low risk for early transfer to lower level of
care and early discharge.
Both 12-lead ECG and ST-recording with Holter tech-
nology have in previous studies been shown to contain
important prognostic information in patients with a suspi-
cion of acute coronary syndromes (4–13,21,22). However,
both these methods have definite limitations. A 12-lead
ECG at rest is only a “snapshot,” unable to reflect the
dynamic nature of coronary thrombosis and myocardial
ischemia. Because 70% to 90% of all ischemic episodes are
silent in these situations (4–9) even repeated 12-lead ECGs
in conjunction with chest pain will often be insufficient.
Long-term 24 to 48 h Holter-recordings might be used for
ST-analysis, but commonly only records 2–3 leads. In a
previous study, 12-lead recordings had a better sensitivity
for detection of ST-episodes compared with 3-lead record-
ings (19). However, the major disadvantage with Holter-
recording is the off line analysis, which means that infor-
Table 2. Number of Patients With ST-Episodes in Relation to
ECG on Admission
n
Number of
Patients With
ST-Episodes %
Normal ECG 206 9 4.4
ST-depression $0.05 mV
,0.10 mV
127 13 10.6
ST-depression $0.10 mV 123 69 54.3
Isolated T-wave
inversions
51 5 9.8
Other pathologic ECG 123 4 3.3
Total 630 100 15.9
n 5 number of patients in each subgroup, defined by ECG on admission. % 5
percentage of patients with ST-episodes in each subgroup.
Table 3. Number of Patients With ST-Episodes in Relation to
Diagnosis Within 24 H of Admission
n
Number of
Patients With
ST-Episodes %
Acute myocardial infarction 163 67 41
Unstable angina/Angina 192 16 8
Other cardiac causes 64 7 11
Noncardiac causes/
unknown causes
211 10 5
Total 630 100 15.9
n 5 number of patients in each subgroup, defined by diagnosis within 24 h of
admission. % 5 percentage of patients with ST-episodes in each subgroup.
Table 4. Univariate Analysis of Clinical, Biochemical and
Electrocardiographic Predictors of Cardiac Death or MI
Variables
Relative
Risk 95% CI
Log-rank
p
Age $70 yr 2.64 1.40–5.01 0.002
Male 0.91 0.52–1.62 0.755
Diabetes mellitus 2.62 1.44–4.78 0.001
Hypertension 1.46 0.83–2.58 0.186
Smoking 1.34 0.67–2.68 0.413
Previous myocardial infarction 2.17 1.23–3.83 0.006
Previous revascularisation 0.99 0.47–2.13 0.990
Troponin T $0.10 mg/l 6.95 3.67–13.14 ,0.001
CK-MB $6 mg/l 5.86 3.10–11.09 ,0.001
ST-segment depression
$0.05 mV on admission
ECG
3.18 1.75–5.80 ,0.001
ST-segment depression
$0.10 mV on admission
ECG
3.53 2.00–6.23 ,0.001
Isolated T-wave inversions 1.62 0.69–3.82 0.263
ST-episodes 5.70 3.23–10.04 ,0.001
CI 5 confidence interval; CK-MB 5 Creatinin kinase, MB fraction; ST-episodes 5
Transient ST-segment depression or elevation in any lead of at least 0.1 mV compared
with the reference ECG, lasting for at least 1 min.
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mation obtained might concern events and risks occurring
several hours or days earlier. Therefore, on line methods
using either continuous 12-lead ECG or VCG monitoring
have been developed (14,15). Whereas the continuous
12-lead ECG has been evaluated during thrombolysis in
several studies (23,24), very little has been published con-
cerning the population analyzed in this study.
Patient selection. This is thus far the largest study con-
cerning ST-monitoring in patients admitted to CCU due to
suspicion of an acute coronary syndrome with ECG non-
diagnostic of AMI. The aim of this study was to evaluate
the usefulness of continuous 12-lead ECG for early risk-
stratification in a nonselected CCU population. Accord-
ingly, consecutive patients admitted to CCU were included,
excluding only patients with a definite diagnosis based on
ST-segment elevation or the occurrence of LBBB.
ST-segment monitoring. In this study, 16% of the pa-
tients had ST-episodes during the first 12 h from admission.
The incidence of ST-episodes in previous studies using
Holter or VCG-monitoring in patients with unstable an-
gina has varied widely (11% to 66%), probably mostly due to
different inclusion criteria (4–13,16). Most of the patients
with ST-episodes in this study had only episodes of ST-
segment depression (87%), and only five patients had only
episodes of ST-segment elevation. This is in accordance
with some (6,25), but not all, previous studies (8,9).
Our results suggest that a 6 to 9 h period of monitoring
in this kind of group might be sufficient to answer the
question whether ST-episodes are present or not, because
most (97%) patients with ST-episodes had their first epi-
sode started during the first 6 h from start of monitoring.
This is in contrast with a previous study in which only about
50% had their first ST-episode during the first 12 h of
monitoring (19). However, that study included a different
population with an incidence of ST-episodes of 77%.
Regarding ST-segment monitoring for other purposes, e.g.,
for assessment of the effect on ischemic episodes of a
particular treatment, a longer time of monitoring might be
necessary.
Predictors of outcome. In this study ST-segment moni-
toring with continuous 12-lead ECG was a significant
predictor of both cardiac death alone and the double end
point cardiac death or MI. Patients with ST-episodes had a
5.7-fold risk of death or MI compared with patients without
ST-episodes. These results are in accordance with a recently
published Holter-study by Patel et al. (13) that included a
fairly unselected group with unstable angina, although it
excluded patients with acute MI. In that study, 15% had
ST-episodes during the 48 h of ST-monitoring, with a
subsequent 4.1-fold increased risk of death or MI. How-
ever, none of the previous Holter-studies has shown the
Figure 1. Freedom of cardiac death (A) and cardiac death and MI
(B) during follow-up in patients (a) without, and (b) with,
ST-episodes. Log-rank p , 0.001 for both end points.
Figure 2. Freedom of cardiac death and MI in patients with (a) no
ST-segment depression $0.10 mV on admission-ECG and no
ST-episodes, (b) no ST-segment depression $0.10 mV on
admission-ECG and ST-episodes, (c) ST-segment depression
$0.10 mV on admission-ECG and no ST-episodes, (d) ST-
segment depression $0.10 mV on admission ECG and ST-
episodes. Log-rank p , 0.001 between a and b, p 5 0.005 between
c and d, p , 0.001 between a and d.
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presence of ST-episodes to be a significant predictor of
death or cardiac death alone.
In another study by Andersen et al. (16), including a
population similar to the one in this study, 29% had
ischemic episodes detected as ST-vector magnitude (ST-
VM) episodes during 24 h of VCG monitoring. In that
study 23% and 10% died or had an MI during one-year
follow-up in the group with and without ST-VM episodes,
respectively. The larger proportion of patients with ischemic
episodes in that study was probably due to differences in the
patient population, e.g., a smaller proportion of noncardiac
or unknown causes (20%). However, part of the difference
might also be related to discrepancies between the two
monitoring techniques, e.g., an ST-episode of 0.10 mV
during 12-lead monitoring does not necessarily correspond
to an ST-VM episode of 0.05 mV during VCG monitoring.
In the univariate analysis, age, diabetes mellitus and
previous MI were, as expected, associated with increased
risk of cardiac death or MI. Previous Holter studies have
shown that the presence of ST-episodes independently
predicts future risk of cardiac events in multivariate analyses
(5,8,11,13). However, these studies were performed without
information from the new and sensitive biochemical mark-
ers [CK-MB (mass) and troponin T] which are important
prognostic markers in this population (2,20). In this study,
the occurrence of ST-episodes persisted as an independent
predictor of cardiac death or MI even when these new
biochemical markers were included in the multivariate
analysis. These findings are in accordance with the VCG
study (17), where the occurrence of ST-VM episodes during
24 h of monitoring was an independent predictor of death
and death or MI in a model including clinical variables and
CK-MB (mass).
A limitation with continuous ST-segment monitoring is
the relatively low sensitivity to identify all patients at risk of
cardiac death or MI (56% at 30 days in this study), which
seems to be regardless of the method used (13,16). This
stresses that ST-segment monitoring should be used in
addition to the clinical evaluation and biochemical markers
in the early risk assessment.
Study limitations. There are some limitations to this
study. First, recurrence of chest pain was not registered.
However, several previous studies have convincingly dem-
onstrated ST-episodes to be a better prognostic marker than
recurrence of chest pain (5,8,11,17). Second, although the
monitoring-system enables on-line analysis, all the ST-
trends were analyzed centrally off line. Therefore, a new
study is needed for evaluation of ST-monitoring in clinical
practice, where the individual physicians base their decision
on on line analyses. Third, the individual physician had free
access to the ST-trends online. Thus, the observation of
ST-episodes online might to some extent have influenced
decisions. However, this would be likely to result in an
under- rather than overestimation of the prognostic value of
ST-episodes detected by continuous 12-lead ECG.
Conclusions. Continuous 12-lead ECG monitoring dur-
ing the first 6 to 9 h after admission to CCU provides
prognostic information on line and, thereby, the early risk
stratification in patients with ECG nondiagnostic of AMI
and symptoms suggestive of acute coronary syndromes
might be improved. Therefore continuous online multilead
ST-monitoring is a useful part of the clinical routine, for the
early identification of higher risk patients who need more
intensive treatment than those with lower risk, who may
benefit from a more conservative approach with rapid
transfer to intermediate care and for early discharge.
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